Article
FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of…
medRxiv · 2023 · David Knorr
Key facts
| Title | FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies |
|---|---|
| First author | David Knorr |
| Journal | medRxiv |
| Published | Jan 20, 2023 |
| DOI | 10.1101/2023.01.19.522856 |
| Devices mentioned | K042884, K912666 |
| Product codes mentioned | KPA, MVU, MYA, MXZ, NJT, NKF, NQF, LIQ |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1